Research progress of plant‐derived natural alkaloids in central nervous system diseases
Phytotherapy Research · 2023-11 · 37 (11) · 4885-4907
DOI: 10.1002/ptr.7955 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 16.07.2023. Verfasst von Qingqing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, She…. Hauptthemen laut MEDLINE: Alkaloids, Alzheimer Disease, Plants, Medicinal, Central Nervous System Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 185 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenyang Young and Middle-aged Innovative Talents Support Program, the Joint National Local Engineering Research Center of Fujian and Taiwan Chinese Medicine Molecular Biotechnology.
Abstract (Originalsprache)
Central nervous system (CNS) disease is one of the most important causes of human death. Because of their complex pathogenesis, more and more attention has been paid to them. At present, drug treatment of the CNS is the main means; however, most drugs only relieve symptoms, and some have certain toxicity and side effects. Natural compounds derived from plants can provide safer and more effective alternatives. Alkaloids are common nitrogenous basic organic compounds found in nature, which exist widely in many kinds of plants and have unique application value in modern medicine. For example, Galantamine and Huperzine A from medicinal plants are widely used drugs on the market to treat Alzheimer's disease. Therefore, the main purpose of this review is to provide the available information on natural alkaloids with the activity of treating central nervous system diseases in order to explore the trends and perspectives for the further study of central nervous system drugs. In this paper, 120 alkaloids with the potential effect of treating central nervous system diseases are summarized from the aspects of sources, structure types, mechanism of action and structure–activity relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
ORCID-Profile: Lixia Chen
Förderung
- National Natural Science Foundation of China
- Shenyang Young and Middle-aged Innovative Talents Support Program
- the Joint National Local Engineering Research Center of Fujian and Taiwan Chinese Medicine Molecular Biotechnology
- Fujian Key Laboratory of Chinese Materia Medica
- Fujian University Key Laboratory for Research and Development of TCM Resources
- Fujian University of Traditional Chinese Medicine
- Chuihui Program-Cooperative Research Project of the Ministry of Education
- Liaoning Province Natural Science Foundation
Zitieren
APA
Zhang, Q., Jiang, Q., Sa, K., Liang, J., Sun, D., Li, H., & Chen, L. (2023). Research progress of plant‐derived natural alkaloids in central nervous system diseases. Phytotherapy Research, 37(11), 4885-4907. https://doi.org/10.1002/ptr.7955
Vancouver
Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, et al. Research progress of plant‐derived natural alkaloids in central nervous system diseases. Phytotherapy Research. 2023;37(11):4885-4907. doi:10.1002/ptr.7955
BibTeX
@article{Zhang2023,
author = {Zhang, Qingqing and Jiang, Qinghua and Sa, Kuiru and Liang, Junming and Sun, Dejuan and Li, Hua and Chen, Lixia},
title = {Research progress of plant‐derived natural alkaloids in central nervous system diseases},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {11},
pages = {4885--4907},
doi = {10.1002/ptr.7955}
}
EUVIMED